growth hormone releasing factor


Also found in: Medical, Wikipedia.
Related to growth hormone releasing factor: somatocrinin

growth′ hor`mone releas′ing fac`tor


n.
a substance produced in the hypothalamus that regulates the release of growth hormone.
References in periodicals archive ?
8) And growth hormone releasing factor triggers the production of growth hormone.
Egrifta, the first FDA-approved treatment for lipodystrophy, is a growth hormone releasing factor (GRF) drug that is administered in a once-daily injection.
Design and biological activity of analogs of growth hormone releasing factor with potential amphiphilic helical carboxyl termini.
The company also confirmed that it has requested a meeting with the Food and Drug Administration (FDA) in the United States to discuss advancing ThGRF (TH9507), an analogue of growth hormone releasing factor, into late-stage development.
The name's initial letters also reference ghrelin's role as a growth hormone releasing factor.
Theratechnologies is supplying the test-drug, TH9507, which is a stabilized analog of human growth hormone releasing factor (GRF).
Investors may have been encouraged by this announcement because Theratechnologies is presently recruiting patients in a Phase 3 clinical trial for a similar indication testing its growth hormone releasing factor analogue, TH9507, with results expected in the fourth quarter of 2006".
ThGRF is Theratechnologies' growth hormone releasing factor analogue, which is slated to enter late-stage development for HIV-associated lipodystrophy in 2005.
Effects of TH9507, a Growth Hormone Releasing Factor (GRF) Analogue, on body composition in patients with abdominal fat accumulation associated with HIV-lipodystrophy syndrome.
Theratechnologies' ThGRF is a stabilized analogue of the natural peptide called growth hormone releasing factor.
Theratechnologies (TSX:TH) announces today that data obtained from its Phase II study to evaluate the safety of ThGRF, its growth hormone releasing factor analogue, in patients with type II diabetes shows that ThGRF is safe and well-tolerated and does not interfere with glycemic control in type II diabetic patients.
The release of growth hormone from the pituitary is regulated by the blood levels of growth hormone releasing factor, which is produced by the hypothalamus.

Full browser ?